Orum Therapeutics, Inc. (KOSDAQ:475830)

South Korea · Delayed Price · Currency is KRW

59,200

-5,800 (-8.92%)

Sep 1, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biotechnology	135.42B	75.92M
Total	135.42B	75.92M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Korea	-	75.92M
United States	135.42B	-
Total	135.42B	75.92M